The Perseus Foundation

01/06/2025

🐾Since 2003, NCI has been using information from studies of canine cancer to help guide studies of human cancer and vice versa—a field known as comparative oncology. Two NCI efforts, the Comparative Oncology Program (COP) and the Pre-medical Cancer Immunotherapy Network for Canine Trials (PRECINCT), facilitate trials of new therapies for different types of cancer in pet dogs, as well as laboratory studies to learn more about the basics of canine cancer.🐾

12/24/2024

Dear Friends,

A warm hello ❣️. Could you please help us? We are searching for our sweet and Hero Dogs that have undergone BMT, with or without T Cell Infusions. The pups need to be two years post-treatment and in molecular remission. This project is being created with the consent of Dr. Sullivan at Bellingham Veterinary.

We are so excited about sharing a revised presentation with pet owners who are in search of information.

Please be assured that only the first name, age, and diagnosis will be listed in the presentation. Also, please feel to share this Call to Action!

If you are able to help us out, please let us know and we will provide you with Rakel’s contact information. If you are so inclined, please take a peek at the previous presentation. 🌟🐾

https://youtu.be/WasI7hS96D0?si=g7KPC6Fj4zdMDjnq

Thank you so much for considering our request. We so appreciate you!

12/23/2024

🎄🐾✨Wishing you a beautiful season filled with sweetness, and magical surprises. May you sparkle with holiday joys! A Merry, Merry Christmas and Happy Holidays, to one and all.❤️🎄❤️

12/18/2024

Excellence in care Flint Animal Cancer Center at CSU VTH ❤️🐾❤️

As a pet owner and a veterinarian, the worst thing is knowing there is something that can be done for a cancer fighter but not having the means to do so. Unfortunately, some clients face this unfair reality. With the help of their donors , they are giving families a fighting chance.

In 2008, the Flint Animal Cancer Center opened its first patient assistance grant fund. Since then, they have opened several more funds that provide financial support to families who have exhausted all other means to treat their pets.

Since then, they have given hundreds of thousands of dollars to families to fight cancer.

These faces have a fighting chance because of you. Thank YOU for giving to patient assistance funds! ❤️

12/18/2024

Friends,

Learn more about ACI Biosciences' fully-funded clinical trial to assess a novel investigational treatment for oral melanoma (Stage II & III) in dogs. Take this short survey to see if your pet is eligible (https://lnkd.in/eum4iuV6) "/linkBuilder_6rq4H71FIda3qKutMj4WIk") or learn more about participating locations at https://lnkd.in/gZFEA24V

12/14/2024

At ACI Biosciences, they are dedicated to advancing care for pets with cancer through innovative clinical trials. Pet cancer is a challenge, but together with veterinarians, researchers, and pet families, they are working to improve treatment options and outcomes.

If you’re interested in exploring clinical trials for your pet, learn more about their work at https://lnkd.in/eeAE3rtG .

Let’s spread awareness and hope for all pets battling cancer.

12/06/2024

Promising and Exciting News from PetCure Oncology. Improving Outcomes for Canine B-Cell. PetCure Oncology🐾❤️🐾

PetCure Oncology Clifton, NJ is now treating patients from the northeastern U.S. including NY, NJ, CT, DE, MA and more!

At PetCure Oncology in Clifton, NJ, improving outcomes for pets with cancer is not just their mission—it’s their passion. One of the most common cancers is B-cell lymphoma in dogs.

During consultations, their team collaborates with pet families to design customized treatment plans that balance successful outcomes by minimizing toxicity, and reducing stress for both the patient and their caregivers.

A recent study has brought exciting new insights into chemotherapy protocols for peripheral nodal B-cell lymphoma. Published in a European multicenter retrospective cohort study, the findings reveal comparable outcomes between a 19-week (CHOP-19) and 25-week (CHOP-25) chemotherapy protocol.

This new evidence allows them to offer treatment plans that minimize treatment duration without compromising effectiveness—a key consideration for pet families seeking the best care that emphasizes the quality of life and comfort of the patient.

Read the study:
Comparison of CHOP-19 and CHOP-25 for treatment of peripheral nodal B-cell lymphoma in dogs: A European multicenter retrospective cohort study

Further reading:
B-Cell Lymphoma in Dogs: The Role of Half-Body Radiation Therapy with Chemotherapy for a More Robust Treatment Protocol and Increased Survival Times

☎️ For detailed information please call: 833.738.4376

12/03/2024

Spotlight on UW Veterinary Cancer Center 🐾

12/02/2024

Thank you SO MUCH Reesa for your sweet reminder about Giving Tuesday🐾💛🐾❤️🐾.

On behalf of Lucy, Leo and Lulu we are so very grateful we thank you ever so much ❣️

12/01/2024

As Pet Cancer Awareness month wraps up, we would be remiss in not sharing "Talking To Your Vet" with you. PetCure Oncology has amazing writeups. 🐾💛🐾

https://petcureoncology.com/wp-content/uploads/Talking-To-Your-Vet-About-Cancer-20240524.pdf

11/28/2024

T cell therapy refers to a type of cancer treatment that harnesses the power of the immune system to help in the combat against cancer. In the case of B cell lymphoma, immune cells are collected, selected, expanded and activated to ignite an immune attack on the cancer cells. Recruiting the patients’ own T cells to attack the tumor is a revolutionary approach to combat lymphoma.

A brief look at Aurelius Biotherapeutics T Cell Therapy for B Cell Study.

11/28/2024

Guess what is coming up?! Giving Tuesday is Tuesday, December 3, 2024. We sincerely hope that all the wonderful non profits that participate are hugely successful and reach their goals. Let’s make this the best donation year EVER. 🐾❤️🐾 Thank you so much for sharing and caring.

11/28/2024

Friends,

May abundance and joy fill your homes this Thanksgiving Day. 🍁🧡🍂

Please click the image to view your ecard!

11/27/2024

Bellingham Veterinary specializes in hope.

We have introduced sweet Lucy who will be traveling to Bellingham for a BMT. There are three other pups who will be traveling soon. Let’s cheer them on so their BMTs are hugely successful!

🐾Specializing In Hope 🐾

Bellingham is the only private veterinary hospital in the country to offer bone marrow transplantation for the treatment of canine lymphoma. Such treatments have given countless canine companions a new lease on life, not to mention more time with their loving humans.

Lymphoma is one of the most common forms of canine cancer, and it is our sincere hope that the cutting-edge research we’re currently conducting into its origins and behavior will eventually lead to its cure. If your dog has been diagnosed with cancer, trust in their knowledge, experience, and expertise to battle lymphoma .

For information, please reach out to Bellingham Veterinary at 360.734.0720.

11/25/2024

Let’s send Lucy and her family love, our kindest, warmest and biggest wishes for a hugely successful BMT. Stay tuned as the story unfolds. 🐾💓🐾

Sweet Lucy, we are rooting for you❣️

https://www.msn.com/en-ca/health/other/ns-couple-seeks-to-save-dog-from-cancer-using-stem-cell-treatment-only-available-in-us/ar-AA1uhCn1

11/25/2024

Discovering that your pet has cancer can be overwhelming and frightening. But you don't have to face this journey alone. In their "Navigating a Pet's Cancer Diagnosis" three-part blog series, Heidi Brenegan, our Chief Marketing Officer, ARRC, shares her personal experience with her dog's recent cancer diagnosis.

Begin the blog series here for Heidi's candid and heartfelt account of processing and navigating this challenging time: https://aercmn.com/navigating-a-pets-cancer-diagnosis-part-1/

Heidi Brenegan, Chief Marketing Officer at Animal Emergency & Referral Center of Minnesota, shares her dog's cancer story.